Sr Director, Global Medical Affairs, HematologyCSL Behring, King of Prussia, PA, USAKing of Prussia, Pennsylvania, United States
OC 52.1 - Assessing the safety profile of AMT-060 and etranacogene dezaparvovec gene therapies across clinical trials in people with severe/moderately severe hemophilia B
Tuesday, June 27, 202310:45 – 11:00 ET
